US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Avalyn Pharma

28.13

+0.71002.59%

Post-market: 28.130.00000.00%19:30 EDT

Volume:526.20K

Turnover:14.87M

Market Cap:1.25B

PE:-12.07

High:28.92

Open:28.59

Low:27.72

Close:27.42

52wk High:40.17

52wk Low:24.15

Shares:44.33M

Float Shares:16.67M

Volume Ratio:1.62

T/O Rate:3.16%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.3300

EPS(LYR):-87.7434

ROE:-68.34%

ROA:-41.74%

PB:3.13

PE(LYR):-0.32

Loading ...

Overview Company News Filings

Press Release: Avalyn Reports First Quarter 2026 Financial Results and Recent Business Highlights

Avalyn Pharma initiated with an Outperform at Evercore ISI

This Avalyn Pharma Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Avalyn Pharma Initiated at Overweight by Morgan Stanley

Jefferies Initiates Avalyn Pharma at Buy With $52 Price Target

MT Newswires Live

Avalyn Pharma initiated with an Overweight at Morgan Stanley

U.S. RESEARCH ROUNDUP-Apollo, Phillips 66, Valero Energy

Analyst Reiterates Buy on Avalyn, Citing Inhaled IPF/PPF Pipeline and Multiple Revenue Streams to Support $52 Price Target

Avalyn Pharma initiated with a Buy at Jefferies

U.S. RESEARCH ROUNDUP- Analog Devices, Crowdstrike, Deere & Co

Avalyn Pharma Inc : Guggenheim Initiates Coverage With Buy Rating; Target Price $80

THOMSON REUTERS

BRIEF-Avalyn Announces Additional Long-Term Data On Ap01, Inhaled Pirfenidone, For The Treatment Of Pulmonary Fibrosis

Avalyn to present 4-year ATLAS data for inhaled pirfenidone AP01 at EULAR 2026

Avalyn Announces Additional Long-Term Data on AP01, Inhaled Pirfenidone, for the Treatment of Pulmonary Fibrosis to Be Presented at the European Alliance of Associations for Rheumatology 2026

THOMSON REUTERS

Novo Holdings acquires 555,555 Avalyn Pharma common shares for $10 million

Avalyn presents AP01 eFlow nebulizer usability study data at ATS 2026

Major Insider Moves Signal Growing Confidence in Avalyn Pharma

Avalyn Pharma Closes Initial Public Offering

MT Newswires Live

Top Midday Gainers

MT Newswires Live

Avalyn Pharma indicated to open at $25.25, IPO priced at $18.00

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/AVLN/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"AVLN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AVLN\",,,,,undefined,":{"symbol":"AVLN","market":"US","secType":"STK","nameCN":"Avalyn Pharma","latestPrice":28.13,"timestamp":1790971200000,"preClose":27.42,"halted":0,"volume":526199,"hourTrading":{"tag":"盘后","latestPrice":28.13,"preClose":28.13,"latestTime":"19:30 EDT","volume":3225,"amount":90719.25,"timestamp":1790983804404,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.02589350838803783,"floatShares":16666700,"shares":44333095,"eps":-2.33,"marketStatus":"Market Closed","change":0.71,"latestTime":"10-02 16:00:00 EDT","open":28.59,"high":28.92,"low":27.72,"amount":14868540.991102,"amplitude":0.043764,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.33,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"listingDate":1777521600000,"exchange":"NASDAQ","adjPreClose":27.42,"preHourTrading":{"tag":"盘前","latestPrice":29.06,"preClose":27.42,"latestTime":"09:29 EDT","volume":3010,"amount":84799.02634,"timestamp":1790947770074,"change":1.64,"changeRate":0.05981,"amplitude":0.047775},"postHourTrading":{"tag":"盘后","latestPrice":28.13,"preClose":28.13,"latestTime":"19:30 EDT","volume":3225,"amount":90719.25,"timestamp":1790983804404,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.6219064428262724,"impliedVol":0.6694,"impliedVolPercentile":0.5333},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AVLN\",,,,,undefined,":{"symbol":"AVLN","floatShares":16666700,"roa":"-41.74%","roe":"-68.34%","lyrEps":-87.743381,"volumeRatio":1.6219064428262724,"shares":44333095,"dividePrice":0,"high":28.92,"amplitude":0.043764,"preClose":27.42,"low":27.72,"week52Low":24.15,"pbRate":"3.13","week52High":40.17,"institutionHeld":0,"latestPrice":28.13,"eps":-2.33,"divideRate":0,"volume":526199,"delay":0,"ttmEps":-2.33,"open":28.59,"prevYearClose":18,"prevWeekClose":28.08,"prevMonthClose":28.49,"prevQuarterClose":28.49,"fiveDayClose":28.08,"twentyDayClose":35.44,"sixtyDayClose":28.92},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AVLN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-12","symbol":"AVLN","fiscalQuarterEnding":"2026/06","expectedEps":-1.03,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786507200000,"reportTimeType":"pre","actualEps":-0.98}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AVLN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AVLN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.6,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":5,"updateTime":1781755200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AVLN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AVLN","date":"2026-10-02","current":-12.072961,"percent":0.981132,"low":-16.842577,"twenty":-15.383041,"median":-14.069191,"eighty":-13.181374,"high":-8.833116,"avg":-14.202014,"sd":1.333723,"marketCap":1215613464},"quantilePoints":[{"date":"2026-05-01","current":-14.471589,"twenty":-13.343894,"median":-11.652352,"eighty":-9.960811,"marketCap":1233037266},{"date":"2026-05-08","current":-13.215324,"twenty":-14.430368,"median":-13.598092,"eighty":-13.264397,"marketCap":1125998425},{"date":"2026-05-15","current":-15.026112,"twenty":-14.666899,"median":-14.368536,"eighty":-13.42143,"marketCap":1280284879},{"date":"2026-05-22","current":-13.941602,"twenty":-14.643344,"median":-13.941602,"eighty":-13.42143,"marketCap":1187880255},{"date":"2026-05-29","current":-13.931787,"twenty":-14.643344,"median":-13.931787,"eighty":-13.215324,"marketCap":1187044014},{"date":"2026-06-05","current":-13.244767,"twenty":-14.510847,"median":-13.774754,"eighty":-13.102456,"marketCap":1128507148},{"date":"2026-06-12","current":-13.774754,"twenty":-14.471589,"median":-13.774754,"eighty":-13.161343,"marketCap":1173664159},{"date":"2026-06-18","current":-14.383258,"twenty":-14.479441,"median":-13.794383,"eighty":-13.204528,"marketCap":1225511097},{"date":"2026-06-26","current":-13.585419,"twenty":-14.649233,"median":-13.936694,"eighty":-13.238878,"marketCap":1284773093},{"date":"2026-07-02","current":-14.143275,"twenty":-14.655122,"median":-14.03484,"eighty":-13.265378,"marketCap":1337529476},{"date":"2026-07-10","current":-13.557292,"twenty":-14.643344,"median":-13.937009,"eighty":-13.265378,"marketCap":1282113107},{"date":"2026-07-17","current":-12.038425,"twenty":-14.576758,"median":-13.784568,"eighty":-13.15846,"marketCap":1138473879},{"date":"2026-07-24","current":-13.937009,"twenty":-14.519455,"median":-13.774754,"eighty":-13.193732,"marketCap":1318022914},{"date":"2026-07-31","current":-13.740119,"twenty":-14.495144,"median":-13.755125,"eighty":-13.157019,"marketCap":1299403014},{"date":"2026-08-07","current":-15.329303,"twenty":-14.523759,"median":-13.762486,"eighty":-13.165961,"marketCap":1449692206},{"date":"2026-08-14","current":-15.696852,"twenty":-14.725787,"median":-13.774754,"eighty":-13.189862,"marketCap":1621704615},{"date":"2026-08-21","current":-15.932863,"twenty":-15.087944,"median":-13.934398,"eighty":-13.227101,"marketCap":1646087817},{"date":"2026-08-28","current":-15.666815,"twenty":-15.573456,"median":-13.941602,"eighty":-13.249768,"marketCap":1618601298},{"date":"2026-09-04","current":-15.207667,"twenty":-15.433025,"median":-14.088821,"eighty":-13.261019,"marketCap":1571164886},{"date":"2026-09-11","current":-14.877252,"twenty":-15.620135,"median":-14.133223,"eighty":-13.26914,"marketCap":1537028403},{"date":"2026-09-18","current":-14.345155,"twenty":-15.433221,"median":-14.265483,"eighty":-13.287874,"marketCap":1482055365},{"date":"2026-09-25","current":-12.251097,"twenty":-15.425244,"median":-14.133223,"eighty":-13.26914,"marketCap":1265709862},{"date":"2026-10-02","current":-11.766203,"twenty":-15.383041,"median":-14.069191,"eighty":-13.181374,"marketCap":1215613464}],"updateTime":1791039155828},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AVLN\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2640906579","title":"Press Release: Avalyn Reports First Quarter 2026 Financial Results and Recent Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2640906579","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640906579?lang=en_us&edition=fundamental","pubTime":"2026-06-03 19:00","pubTimestamp":1780484400,"startTime":"0","endTime":"0","summary":"On track to complete enrollment of MIST Phase 2b trial of AP01 in progressive pulmonary fibrosis  in mid-2026, with newly presented long term open-label extension clinical data that support favorable tolerability profile. Enrollment underway in AURA Phase 2 trial of AP02 in patients with idiopathic pulmonary fibrosis  with topline data anticipated by the end of 2027. Upsized initial public offering  gross proceeds of $345.0 million, together with approximately $123.1 million in cash, cash equivalents, and marketable securities as of March 31, 2026, projected to be sufficient to fund operations into 2029. BOSTON, June 03, 2026  -- Avalyn Pharma Inc. , a clinical-stage biopharmaceutical company pioneering inhaled therapies to transform the treatment paradigm of serious, rare respiratory diseases, today announced financial results for the first quarter ended March 31, 2026 and recent business highlights.-- MIST Phase 2b Trial On-Track to Complete Enrollment Mid-2026, with. placebo-control","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","ATS","R","BK4007","BK4161","BK4232","IPO","AVLN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638545519","title":"Avalyn Pharma initiated with an Outperform at Evercore ISI","url":"https://stock-news.laohu8.com/highlight/detail?id=2638545519","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638545519?lang=en_us&edition=fundamental","pubTime":"2026-05-26 22:52","pubTimestamp":1779807144,"startTime":"0","endTime":"0","summary":"Evercore ISI analyst Gavin Clark-Gartner initiated coverage of Avalyn Pharma (AVLN) with an Outperform rating and $51 price target Avalyn has “a st...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/avalyn-pharma-initiated-with-an-outperform-at-evercore-isi-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/avalyn-pharma-initiated-with-an-outperform-at-evercore-isi-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AVLN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638483745","title":"This Avalyn Pharma Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday","url":"https://stock-news.laohu8.com/highlight/detail?id=2638483745","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638483745?lang=en_us&edition=fundamental","pubTime":"2026-05-26 20:56","pubTimestamp":1779800160,"startTime":"0","endTime":"0","summary":"Top Wall Street analysts changed outlook on top names. See analyst ratings page for all changes. Analysts have mixed views on AVLN stock.","market":"hk","thumbnail":"https://cdn.benzinga.com/cdn-cgi/image/width=260,dpr=2,format=auto,quality=85/files/images/story/2026/05/26/Analysts-Debate-Depreciation-Impact.jpeg","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/cdn-cgi/image/width=260,dpr=2,format=auto,quality=85/files/images/story/2026/05/26/Analysts-Debate-Depreciation-Impact.jpeg"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/news/26/05/52774838/this-avalyn-pharma-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-tuesday","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/26/05/52774838/this-avalyn-pharma-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-tuesday","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["BK4007","AVLN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638511624","title":"Avalyn Pharma Initiated at Overweight by Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2638511624","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638511624?lang=en_us&edition=fundamental","pubTime":"2026-05-26 19:44","pubTimestamp":1779795840,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AVLN/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 26, 2026 07:44 ET (11:44 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVLN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638519325","title":"Jefferies Initiates Avalyn Pharma at Buy With $52 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2638519325","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638519325?lang=en_us&edition=fundamental","pubTime":"2026-05-26 19:14","pubTimestamp":1779794088,"startTime":"0","endTime":"0","summary":"(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AVLN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638451851","title":"Avalyn Pharma initiated with an Overweight at Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2638451851","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638451851?lang=en_us&edition=fundamental","pubTime":"2026-05-26 17:21","pubTimestamp":1779787312,"startTime":"0","endTime":"0","summary":"Morgan Stanley initiated coverage of Avalyn Pharma (AVLN) with an Overweight rating and $53 price target The company is well positioned to address ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/avalyn-pharma-initiated-with-an-overweight-at-morgan-stanley-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/avalyn-pharma-initiated-with-an-overweight-at-morgan-stanley-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AVLN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638599444","title":"U.S. RESEARCH ROUNDUP-Apollo, Phillips 66, Valero Energy","url":"https://stock-news.laohu8.com/highlight/detail?id=2638599444","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638599444?lang=en_us&edition=fundamental","pubTime":"2026-05-26 15:31","pubTimestamp":1779780675,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Apollo, Phillips 66, Valero Energy May 26 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Apollo, ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nL4N4230EE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AAPL","GOOGL","GOOY","ALNT","DLTR","BRX","CBT","AIZ","CINF","CSCO","BJ","BAH","CRCO","CRCA","GOOW","GOOX","CORD","MACW.SI","BOW","APO","CRWV","APA","ADI","CCUP","ALB","AD","CIEN","CRBP","BCML","DELL","GOU","ALAB","CRCD","CRCG","CGNX","AAP","AFL","ADSK","CASY","BBIO","BLTE","CDNS","CRCL","DECK","AFG","D","AVLN","CMI","CHWY","DCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638537028","title":"Analyst Reiterates Buy on Avalyn, Citing Inhaled IPF/PPF Pipeline and Multiple Revenue Streams to Support $52 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2638537028","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638537028?lang=en_us&edition=fundamental","pubTime":"2026-05-25 19:26","pubTimestamp":1779708363,"startTime":"0","endTime":"0","summary":"Roger Song, an analyst from Jefferies, has initiated a new Buy rating on Avalyn Pharma Inc (AVLN). Roger Song has given his Buy rating due to a com...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/analyst-reiterates-buy-on-avalyn-citing-inhaled-ipf-ppf-pipeline-and-multiple-revenue-streams-to-support-52-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/analyst-reiterates-buy-on-avalyn-citing-inhaled-ipf-ppf-pipeline-and-multiple-revenue-streams-to-support-52-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AVLN","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638537948","title":"Avalyn Pharma initiated with a Buy at Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2638537948","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638537948?lang=en_us&edition=fundamental","pubTime":"2026-05-25 19:05","pubTimestamp":1779707104,"startTime":"0","endTime":"0","summary":"Jefferies initiated coverage of Avalyn Pharma (AVLN) with a Buy rating and $52 price target The firm says the company is “solving right problem in ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/avalyn-pharma-initiated-with-a-buy-at-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/avalyn-pharma-initiated-with-a-buy-at-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AVLN","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638366536","title":"U.S. RESEARCH ROUNDUP- Analog Devices, Crowdstrike, Deere &  Co","url":"https://stock-news.laohu8.com/highlight/detail?id=2638366536","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638366536?lang=en_us&edition=fundamental","pubTime":"2026-05-25 16:32","pubTimestamp":1779697943,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP- Analog Devices, Crowdstrike, Deere &  CoMay 25 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including An","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260525:nL4N4220EH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRWL","IE00BZ199S13.USD","BK4515","LU0511384066.AUD","BJ","LU0314104364.USD","DE","PANG","AVLN","DDOG","IE00B19Z8X17.USD","LU1917777945.USD","SG9999011175.SGD","BK4551","LU2023250843.SGD","LU2491049909.HKD","LU2211815571.USD","LU0724618433.USD","BK4152","IE00B1BXHZ80.USD","LU2125909916.SGD","LU1989763690.USD","LU1989764664.SGD","DOGD","LU1923623000.USD","SG9999004303.SGD","LU2286300806.USD","LU2487616109.SGD","LU2298322129.HKD","PS","LU1623119135.USD","LU0868494708.USD","FTNT","LU1670711123.USD","LU2394011477.USD","PALU","HEI","BK4560","LPG","LU2125909247.SGD","LU0477156953.USD","LU2023250504.SGD","IE0008368304.USD","LU0170899867.USD","PALD","CRWD","PANW","LU0124384867.USD","ADI","LU0957808578.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638582653","title":"Avalyn Pharma Inc : Guggenheim Initiates Coverage With Buy Rating; Target Price $80","url":"https://stock-news.laohu8.com/highlight/detail?id=2638582653","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638582653?lang=en_us&edition=fundamental","pubTime":"2026-05-25 12:21","pubTimestamp":1779682872,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260525:nFWN41Z0Y2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","AVLN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637363563","title":"BRIEF-Avalyn Announces Additional Long-Term Data On Ap01, Inhaled Pirfenidone, For The Treatment Of Pulmonary Fibrosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2637363563","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637363563?lang=en_us&edition=fundamental","pubTime":"2026-05-21 20:38","pubTimestamp":1779367120,"startTime":"0","endTime":"0","summary":"BRIEF-Avalyn Announces Additional Long-Term Data On Ap01, Inhaled Pirfenidone, For The Treatment Of Pulmonary FibrosisMay 21 (Reuters) - Avalyn Pharma Inc AVLN.O:AVALYN ANNOUNCES ADDITIONAL LONG-TERM ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nTUAKXWKT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","AVLN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637333281","title":"Avalyn to present 4-year ATLAS data for inhaled pirfenidone AP01 at EULAR 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2637333281","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637333281?lang=en_us&edition=fundamental","pubTime":"2026-05-21 20:01","pubTimestamp":1779364915,"startTime":"0","endTime":"0","summary":"Avalyn Pharma flagged additional long-term data from the ATLAS open-label extension study of AP01, an inhaled version of pirfenidone, with results scheduled for presentation at EULAR 2026 on June 6 in London.The update is set to focus on long-term tolerability in patients with progressive pulmonary fibrosis treated for up to four years.Avalyn also pointed to prior studies suggesting AP01 could help preserve lung function while improving tolerability versus historical oral pirfenidone, a positioning that supports its ongoing Phase 2b MIST trial in progressive pulmonary fibrosis.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nNDL9kwy0p:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00BKPKM429.USD","SG9999014039.USD","LU0314104364.USD","IE00BN0W2W23.USD","AVLN","LU2095319765.USD","LU2210149790.SGD","BK4007","SG9999014021.USD","IE00B3QW5Z07.USD","LU2210150020.SGD","BK4585","SG9999014005.SGD","SG9999014013.SGD","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","NDAQ","BK4112","IE00BN0W2V16.EUR","IE00B64PRP62.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637333431","title":"Avalyn Announces Additional Long-Term Data on AP01, Inhaled Pirfenidone, for the Treatment of Pulmonary Fibrosis to Be Presented at the European Alliance of Associations for Rheumatology 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2637333431","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637333431?lang=en_us&edition=fundamental","pubTime":"2026-05-21 20:00","pubTimestamp":1779364800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nTUAKXWKT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","AVLN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633299269","title":"Novo Holdings acquires 555,555 Avalyn Pharma common shares for $10 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633299269","media":"Reuters","labels":["insiderTrades","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633299269?lang=en_us&edition=fundamental","pubTime":"2026-05-06 04:16","pubTimestamp":1778012202,"startTime":"0","endTime":"0","summary":"Novo Holdings, a 10% owner, lifted its stake in Avalyn Pharma to 3,883,289 voting common shares.Holding increased through conversion of 3,327,734 shares into voting common stock.Novo Holdings also bought 555,555 voting common shares at USD 18 per share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Avalyn Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 05, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nNDL7C7q1x:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Novo Holdings acquires 555,555 Avalyn Pharma common shares for $10 million","news_tag":"insiderTrades,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVLN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633459925","title":"Avalyn presents AP01 eFlow nebulizer usability study data at ATS 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2633459925","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633459925?lang=en_us&edition=fundamental","pubTime":"2026-05-06 04:03","pubTimestamp":1778011381,"startTime":"0","endTime":"0","summary":"Avalyn Pharma flagged new patient-centered research on AP01 delivery and supportive care experiences, with results scheduled for presentation at American Thoracic Society 2026 International Conference in Orlando on May 18, 2026.A usability study of eFlow nebulizer system for inhaled pirfenidone AP01 found patient, care partner, clinician feedback helped refine instructions intended to improve real-world use.Separate research on idiopathic pulmonary fibrosis supportive care highlighted patient demand for faster, clearer communication, stronger care partner involvement, better access to specialist expertise.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nNDLbFxw9M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IE00BN0W2W23.USD","NDAQ","SG9999014005.SGD","LU2210150020.SGD","IE00BN0W2V16.EUR","AVLN","LU2095319765.USD","IE00B3QW5Z07.USD","SG9999014039.USD","IE00BKPKM429.USD","IE00B64PRP62.GBP","IE00BN0W2T93.GBP","BK4588","BK4112","SG9999014013.SGD","LU2210149790.SGD","IE00BGHQF748.EUR","SG9999014021.USD","LU0314104364.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632327621","title":"Major Insider Moves Signal Growing Confidence in Avalyn Pharma","url":"https://stock-news.laohu8.com/highlight/detail?id=2632327621","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632327621?lang=en_us&edition=fundamental","pubTime":"2026-05-02 10:02","pubTimestamp":1777687366,"startTime":"0","endTime":"0","summary":"New insider activity at Avalyn Pharma Inc ( ($AVLN) ) has taken place on May 1, 2026. Avalyn Pharma Inc. has seen notable insider confidence, with ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/major-insider-moves-signal-growing-confidence-in-avalyn-pharma-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/major-insider-moves-signal-growing-confidence-in-avalyn-pharma-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AVLN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632475756","title":"Avalyn Pharma Closes Initial Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2632475756","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632475756?lang=en_us&edition=fundamental","pubTime":"2026-05-02 04:16","pubTimestamp":1777666562,"startTime":"0","endTime":"0","summary":"Avalyn Pharma (AVLN) said late Friday it has closed its initial public offering of about 19.2 million shares at $18 a share, raising $345 million.The clinical-stage biopharmaceutical company said the closing includes the full exercise of an overallotment option.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AVLN","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632650002","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2632650002","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632650002?lang=en_us&edition=fundamental","pubTime":"2026-05-01 02:29","pubTimestamp":1777573776,"startTime":"0","endTime":"0","summary":"Avalyn Pharma , a clinical-stage drugmaker, said late Wednesday it has priced its upsized initial public offering of about 16.7 million shares at $18.00 apiece, targeting gross proceeds of about $300 million.Shares soared in their trading debut on Nasdaq, up over 50% at about $27.44 in afternoon trading, with intraday trading volume of over 3.65 million.Everspin Technologies  reported Thursday an agreement with a US prime contractor to provide Toggle MRAM process technology and engineering services for United States Defense Industrial Base customers. The agreement is valued at $40.0 million and will run over two-and-a-half years.Shares surged 37% as intraday trading volume soared to over 12.6 million from a daily average of about 533,000.Viavi Solutions  jumped 15% after its fiscal Q3 results and fiscal Q4 guidance exceeded market expectations.More than 15.1 million shares traded intraday, compared with a daily average of about 5.87 million.Price: 27.00, Change: +9.00, Percent Change: ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2065171402.SGD","LU2065170008.USD","LU0240878834.USD","LU0240877869.USD","AVLN","LU2065171311.SGD","LU0205194284.USD","VIAV","LU0205193047.USD","LU2065169927.USD","BK4020","LU1559883803.SGD","BK4141","LU0566484027.USD","MRAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632501116","title":"Avalyn Pharma indicated to open at $25.25, IPO priced at $18.00","url":"https://stock-news.laohu8.com/highlight/detail?id=2632501116","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632501116?lang=en_us&edition=fundamental","pubTime":"2026-05-01 02:10","pubTimestamp":1777572602,"startTime":"0","endTime":"0","summary":"12:03 EDT Avalyn Pharma (AVLN) indicated to open at $25.25, IPO priced at $18.00 Published first on TheFly – the ultimate source for real-time, mar...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/avalyn-pharma-indicated-to-open-at-25-25-ipo-priced-at-18-00-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/avalyn-pharma-indicated-to-open-at-25-25-ipo-priced-at-18-00-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SPCX","IPOS","AVLN"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":52,"code":"91000000","status":"200"}]}}